Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has issued an announcement.
Sinco Pharmaceuticals Holdings Limited has announced a board meeting scheduled for March 28, 2025, to discuss and approve the annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and distribution of pharmaceutical products.
YTD Price Performance: -13.00%
Average Trading Volume: 392,692
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$363.9M
For an in-depth examination of 6833 stock, go to TipRanks’ Stock Analysis page.